Nephrolithiasis: Clinical Trials

3 trials for Nephrolithiasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Terminated 3
Phase 21Terminated 1

Follow Nephrolithiasis: new trials by email Literature Review of Nephrolithiasis trials Research Report on Nephrolithiasis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Establishing the Safety and Efficacy of Reloxaliase in Patients With Enteric Hyperoxaluria
Reloxaliase, Placebo - Enteric Hyperoxaluria
Phase 3TerminatedAllena Pharmaceuticals922019-08-262022-06-10
Effectiveness of Silodosin in Medical Expulsive Therapy for Ureteral Pelvic Stone From 4 to 10 mm.
Silodosin - Kidney Stone, Expulsive Medical Therapy
Phase 3TerminatedCentre Hospitalier Departemental Vendee82014-07-012016-02-11
Dose-Dependent Effect of Thiazide in Dent's Disease Hypercalciuria
Hydrochlorothiazide - Dent's Disease, Nephrolithiasis
Phase 2 / Phase 3TerminatedAssistance Publique - Hôpitaux de Paris102003-07-012008-03-19

Narrower conditions

Kidney Calculi (2)  ·  Dent Disease (1)  ·  Hyperoxaluria (1)

Broader conditions

Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Kidney Diseases (3)  ·  Male Urogenital Diseases (3)  ·  Urogenital Diseases (3)  ·  Urolithiasis (3)  ·  Urologic Diseases (3)  ·  Calculi (2)  ·  Pathological Conditions, Anatomical (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Urinary Calculi (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Genetic Diseases, X-Linked (1)

Interventions

Hydrochlorothiazide (1)  ·  oxalate decarboxylase (1)  ·  reloxaliase (1)  ·  silodosin (1)

Sponsors

Allena Pharmaceuticals (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Centre Hospitalier Departemental Vendee (1)

Countries

France (3)  ·  Austria (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  Croatia (1)  ·  Germany (1)  ·  Italy (1)  ·  Mexico (1)  ·  Portugal (1)  ·  Romania (1)  ·  Russia (1)  ·  Spain (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

David Clark, MD (1)

Results publications

PMID 18976849

NIH funding

2018 (1)